not tagged
oncxerna therapeutics
['gastric', 'biomarker', 'marker ', 'oncxerna']
oncxerna therapeutics announces new xerna(tm) tme panel biomarker data from retrospective analysis of results from a randomized phase 2 trial evaluating anti-pd-1 maintenance therapy in esophagogastric adenocarcinoma at the esmo congress 2022 
We provide a balanced view on small cap biotech equities.